House committee probes NIH (National Institutes of Health) tissue handling
This article was originally published in Clinica
Leaders of the US House energy and commerce committee have launched an investigation into the handling of human tissue samples at the National Institutes of Health (NIH) after learning that the government research institution has almost no accountability for damaged or lost specimens.
You may also be interested in...
New medicines under evaluation at the European Medicines Agency.
Discussions on the shape of health care have moved from “reimagining” to the next stage: building and executing on the vision. That is the thrust of EY’s NextWave Report: New Horizons 2019. Additionally, for medtechs seeking business continuum, “duality” is now a preoccupying thought.
The idea that public corporations have obligations that extend beyond the fiduciary responsibility to shareholders will be the dominant measure of responsible business behavior in the coming decade. Uncertainty about the extent of these commitments – commonly referenced as the environmental, social and governance (ESG) agenda – has produced equally variable responses from companies in the health care business.